242 related articles for article (PubMed ID: 36697073)
1. The Latest Treatments for Cancer Cachexia: An Overview.
Watanabe H; Oshima T
Anticancer Res; 2023 Feb; 43(2):511-521. PubMed ID: 36697073
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
Currow DC; Skipworth RJ
Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
[TBL] [Abstract][Full Text] [Related]
3. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
Graf SA; Garcia JM
Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
[TBL] [Abstract][Full Text] [Related]
4. Anamorelin for cancer cachexia.
Nishie K; Sato S; Hanaoka M
Drugs Today (Barc); 2022 Mar; 58(3):97-104. PubMed ID: 35274629
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
[TBL] [Abstract][Full Text] [Related]
6. An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia.
Fonseca GWPD; von Haehling S
Expert Opin Pharmacother; 2021 May; 22(7):889-895. PubMed ID: 33491505
[TBL] [Abstract][Full Text] [Related]
7. [The Treatment of Cancer Cachexia].
Tanaka S; Takayama K
Gan To Kagaku Ryoho; 2021 Aug; 48(8):987-991. PubMed ID: 34404062
[TBL] [Abstract][Full Text] [Related]
8. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K
Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ
Nakanishi Y; Higuchi J; Honda N; Komura N
Nihon Yakurigaku Zasshi; 2021; 156(6):370-381. PubMed ID: 34719572
[TBL] [Abstract][Full Text] [Related]
11. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome.
Currow DC; Abernethy AP
Future Oncol; 2014 Apr; 10(5):789-802. PubMed ID: 24472001
[TBL] [Abstract][Full Text] [Related]
12. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
[TBL] [Abstract][Full Text] [Related]
13. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
Temel JS; Abernethy AP; Currow DC; Friend J; Duus EM; Yan Y; Fearon KC
Lancet Oncol; 2016 Apr; 17(4):519-531. PubMed ID: 26906526
[TBL] [Abstract][Full Text] [Related]
14. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
[TBL] [Abstract][Full Text] [Related]
15. [Future Prospects of Cancer Cachexia].
Morita-Tanaka S; Takayama K
Gan To Kagaku Ryoho; 2022 Jul; 49(7):719-722. PubMed ID: 35851337
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Anorexia Cancer Cachexia Syndrome and Potential Benefits of Traditional Medicine and Natural Herbs.
Ming-Hua C; Bao-Hua Z; Lei Y
Curr Pharm Biotechnol; 2016; 17(13):1147-1152. PubMed ID: 27758689
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.
Currow DC; Maddocks M; Cella D; Muscaritoli M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400622
[TBL] [Abstract][Full Text] [Related]
18. Cachexia and anorexia: cancer's covert killer.
Davis MP; Dickerson D
Support Care Cancer; 2000 May; 8(3):180-7. PubMed ID: 10789957
[TBL] [Abstract][Full Text] [Related]
19. Update on the treatment of cancer cachexia.
Nishie K; Nishie T; Sato S; Hanaoka M
Drug Discov Today; 2023 Sep; 28(9):103689. PubMed ID: 37385369
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of Anamorelin for the Treatment of Cancer Cachexia and Factors Associated with Weight Gain].
Okuda Y; Saitoh T; Mikame Y; Shinada M; Fujimura S; Suga R; Kobayashi N; Nakata M; Arai D; Nakazawa T; Yamaguchi H; Imai Y
Gan To Kagaku Ryoho; 2024 May; 51(5):529-533. PubMed ID: 38881063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]